Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 3Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Hematologic Neoplasms 4Anatomic Stage I Breast Cancer AJCC v8 3Pancreatic Neoplasms 1Ovarian Neoplasms 1Oligodendroglioma 1Neoplasms 1Leukemia, Myeloid, Acute 1Hepatitis B 1Glioma 1Depression 1Brenner Tumor 1Astrocytoma 1Anxiety Disorders 1

Interventions

Carboplatin 44Paclitaxel 43liposomal doxorubicin 23Topotecan 19Gemcitabine 18pembrolizumab 17Cyclophosphamide 17Bevacizumab 16Cisplatin 12niraparib 9olaparib 8fludarabine 7Taxes 7Docetaxel 7aldesleukin 6Nivolumab 6Doxorubicin 61-dodecylpyridoxal 6oregovomab 5fludarabine phosphate 5Peripheral Blood Stem Cell Transplantation 5Filgrastim 5rucaparib 4durvalumab 4avelumab 4Surgical Procedures, Operative 4Melphalan 4Ipilimumab 4Interleukin-2 4Etoposide 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Ovarian Neoplasms × Practice Guidelines as Topic × Clear all
NCT03641287 2023-11-29

The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors

University of Washington

Phase NA Terminated
64 enrolled 16 charts
Gynecologic

Brenner Tumor, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡